These data indicated that our AMG risk signature could be a possible prognostic indicator, and the combination with the TP53 mutation status, the STROMAL score, the immune score and the ESTIMATE score could further refine the prognostic prediction for patients with HNSCC. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.